Sun Pharmaceuticals Industries Share Price

Sun Pharma.Inds.

CMP as on 29-Sep-20 15:58

₹ 506.15
-3.95 -0.77%

Open

₹ 517.85

Turnover (lac)

₹ 43,491

Prev. Close

₹ 510.10

Day's Vol (shares)

₹ 85,92,549

Day's Range (₹)

₹ 504.50
₹ 517.85

CMP as on29-Sep-20 15:59

₹ 505.60
-4.6 -0.9%

Open

₹ 516.25

Turnover (lac)

₹ 2,612

Prev. Close

₹ 510.20

Day's Vol (shares)

₹ 3,62,137

Day's Range

₹ 504.65
₹ 516.60

CMP as on 29-Sep-20 15:30

₹ 507.45
-5.45 -1.06%

Open

₹ 517.00

Open Interest(Contracts)

₹ 3,52,47,800

VWAP

₹ 511.45

Day's Vol (shares)

₹ 1,36,22,000

Day's Range (Ex.Dt. 29 Oct 2020)

₹ 506.50
₹ 517.50

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 27-Aug-2020 31-Jul-2020 - -
AGM 27/08/2020 This is to inform you that the 28th Annual General Meeting of the shareholders of the Company would be held on Thursday, August 27, 2020 at 03:30 p.m. IST through Video Conferencing / Other Audio-Visual Means (28th AGM). Further, in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Friday, August 21, 2020 till Thursday, August 27, 2020 (both days inclusive) for the purpose of holding of the 28th AGM and declaration and payment of final dividend for the financial year ended March 31, 2020, subject to approval of the shareholders, at the 28th AGM. (As Per BSE Announcement Dated on 28/07/2020) Submission of Annual Report of the Company for the year ended March 31, 2020 along with the Notice of the 28th Annual General Meeting of the Company. Submission of Newspaper advertisement published regarding i) Notice of the 28th Annual General Meeting of the Company for the financial year 2019-20, to be held on Thursday, August 27, 2020 by Video Conferencing/ Other Audio Visual means, ii) E-voting and iii) Book Closure, under Regulation 30 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Notice of 28th Annual General Meeting of the Company to be held on August 27, 2020, is enclosed herewith along with the Annual Report of the Company for the year ended March 31, 2020. (As per BSE Announcement Dated on 3/8/2020) Proceedings of 28th Annual General Meeting of Sun Pharmaceutical Industries Limited (Company) held on August 27, 2020 pursuant to Clause 13 of Para A of Part A of Schedule III of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations). Chairman Speech at the 28th Annual General Meeting of Sun Pharmaceutical Industries Ltd., held on August 27, 2020 (As per BSE Announcement Dated on 27/8/2020) Voting Results of 28th Annual General Meeting of the Company held on August 27, 2020 in accordance with Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinizers Consolidated Report Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated on 8/29/2020)